Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Anti-SARS-CoV-2 NeutraLISA
Connect with this vendor - Learn about this product

Anti-SARS-CoV-2 NeutraLISA

  • Surrogate virus neutralisation test (sVNT) for determination of neutralising antibodies that inhibit the binding of SARS-CoV-2 S1/RBD to ACE2 receptors
  • Supports evaluation of the immune response following SARS-CoV-2 infection or vaccination with S1/RBD-based vaccines
  • Established ELISA method – automatable and suitable for routine diagnostics, no BSL-3 laboratory required